International Journal of Cancer · 2009 · 185 citations · 60 references
MedicineMolecular BiologyOncologyApoptosisEpigeneticsMolecular OncologyCancer Cell SignalingCancer EpigeneticsEpigenetic Alterations In CancerEpigenetic Regulation In CancerSignal Transduction In CancerTumor Suppressor GenesAnticancer ActivityCancer Signaling PathwaysNucleosome Remodeling ComplexesP53 InactivationP53-dependent Apoptotic SignalingP53-mediated SignalingTranscriptional RepressionTranscriptional Repression Mechanisms
Dietary compounds and epigenetic influences are well recognized factors in cancer progression. Resveratrol (Res), a dietary compound from grapes, has anticancer properties; however, its epigenetic effects are understudied. Metastasis-associated protein 1 (MTA1) is a part of the nucleosome remodeling deacetylation (NuRD) corepressor complex that mediates posttranslational modifications of histones and nonhistone proteins resulting in transcriptional repression. MTA1 overexpression in prostate cancer (PCa) correlates with tumor aggressiveness and metastasis. In this study, we have identified a novel MTA1-mediated mechanism, by which Res restores p53-signaling pathways in PCa cells. We show, for the first time, that Res causes down-regulation of MTA1 protein, leading to destabilization of MTA1/NuRD thus allowing acetylation/activation of p53. We demonstrated that MTA1 decrease by Res was concomitant with accumulation of Ac-p53. MTA1 knockdown further sensitized PCa cells to Res-dependent p53 acetylation and recruitment to the p21 and Bax promoters. Furthermore, MTA1 silencing maximized the levels of Res-induced apoptosis and pro-apoptotic Bax accumulation. HDAC inhibitor SAHA, like MTA1 silencing, increased Res-dependent p53 acetylation and showed cooperative effect on apoptosis. Our results indicate a novel epigenetic mechanism that contributes to Res anticancer activities: the inhibition of MTA1/NuRD complexes due to MTA1 decrease, which suppresses its deacetylation function and allows p53 acetylation and subsequent activation of pro-apoptotic genes. Our study identifies MTA1 as a new molecular target of Res that may have important clinical applications for PCa chemoprevention and therapy, and points to the combination of Res with HDAC inhibitors as an innovative therapeutic strategy for the treatment of PCa.
60
A matrix metalloproteinase expressed on the surface of invasive tumour cells
Hiroshi Sato, Takahisa Takino, Yasunori Okada et al. · Nature · 1994 · 2.6K citations
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Michael S. Finnin, Jill R. Donigian, Alona Cohen et al. · Nature · 1999 · 1.7K citations
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
Bharat B. Aggarwal, Anjana Bhardwaj, Rishi S. Aggarwal et al. · PubMed · 2004 · 1.4K citations
Medicine, Oncology, Pharmacology +13
FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma
Bhupinder Mann, John R. Johnson, Martin H. Cohen et al. · The Oncologist · 2007 · 1.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +14